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Abstract
The Community Antiretroviral (ARV) Therapy Support Group (CASG) program aims to address 
low retention rates in Mozambique’s HIV treatment program and the absorptive capacity of the 
country’s health facilities. CASG provides patients with the opportunity to form groups, whose 
members provide peer support and collect ARV medications on a rotating basis for one another. 
Based on the promising results in one province, a multi-site level evaluation followed. We report 
on qualitative findings from this evaluation from the patient perspective on the role of social 
relationships (as facilitated through CASG) in conferring time, financial, educational and 
psychosocial benefits that contribute to improved patient retention. These findings may be helpful 
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in informing what aspects of social relationships are critical to foster as CASG is implemented 
within a greater number of Mozambican health facilities, and as other countries design and 
implement related models of care and treatment with a support group component.
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Background
The Community Antiretroviral (ART) Support Group (CASG) Program
Mozambique experiences relatively low antiretroviral therapy (ART) retention rates in its 
HIV treatment program [1]. While some patients are moving to receiving 3-month 
prescriptions for antiretroviral (ARV) medications under pilot programs, many patients in 
Mozambique must still visit every month to collect their ARVs. Such frequent visits are 
challenging for patients to sustain, likely contributing to Mozambique’s low retention rates 
since key reasons for attrition include: time spent getting to health facilities; wait time at 
over-burdened health facilities; and transportation costs [2–5]. National health systems must 
consequently devise strategies that address these root causes of ART-related attrition if their 
treatment goals, including those at the global level [6], are to be met.
In response, the Ministry of Health (MoH) in Mozambique has pioneered a model of care 
and treatment, the CASG program, aimed at addressing low retention rates and its health 
facilities’ absorptive capacity. Adult patients stable on ART for more than 6 months with a 
CD4 count > 200 cells/µL, are not pregnant, and who do not have any active World Health 
Organization stage III or IV conditions are eligible to participate. The CASG program 
provides patients with the opportunity to form groups, typically comprising four to six 
patients living in close proximity, who collect ARVs for one another on a rotating basis and 
provide peer support.
Every month a different CASG member visits the health facility, after having collected 
information on the health status of the other group members. The CASG member receives 
clinical follow-up, shares information with the clinician on the health status of the other 
group members, collects a monthly supply of ARVs, and subsequently meets with the other 
group members to distribute their medications and share information from the health facility.
Medecins Sans Frontieres initially piloted the CASG program in one Mozambican province 
(i.e., Tete Province). Based on its promising results in improving retention, decreasing loss 
to follow up, decreasing mortality, and decreasing health facility burden [7–12], the 
Mozambican MoH subsequently expanded the program beyond Tete to 69 sites (at the time 
of our study).
Support Groups for Individuals Living with HIV/AIDS
While prior studies in resource limited settings demonstrate that support group participation 
can contribute to improved treatment adherence and retention [7, 11–16], less is known 
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about the mechanisms through which support groups do so. A body of literature is emerging, 
and relevant themes are reflected below regarding how support groups can facilitate 
adherence and retention.
Time and Financial Related Benefits—The CASG pilot in Tete Province demonstrated 
that participation conferred time and cost savings in only having to visit the health facility 
once every 6 months (rather than monthly). Program participation also provided access to 
financial support as those participating in CASG may choose to pool funds to support group 
members when needing assistance with food, transportation or health care costs [8–10, 12]. 
A study in Zimbabwe similarly found that support groups facilitated access to financial 
assistance from other group members [17]. A study in Rwanda involving HIV positive 
women demonstrated that other financial benefits could additionally accrue from support 
group involvement, as women reported being able to return to work because of improved 
mental and physical health resulting from their participation [18].
Educating About Treatment Adherence—The CASG pilot in Tete further 
demonstrated that program participation facilitated information sharing amongst group 
members about disease progression and the importance of daily drug intake [8–10]. Support 
group members in the Rwandan study of HIV positive women reported similar findings [18]. 
The study in Zimbabwe additionally detailed how HIV positive support group participants 
encouraged each other to continue attending clinical appointments [17], and a South African 
study found that the dynamics in a patient’s social environment could serve to encourage a 
healthy lifestyle and promote HIV treatment adherence [19]. Support group participation 
may thus facilitate greater awareness and understanding of the importance of treatment 
adherence and/or actively promote it.
Contributing to Acceptance, Belonging, and Diminished Shame and Stigma—
The CASG pilot in Tete demonstrated that participating in the program decreased feelings of 
isolation in living with HIV, and conferred a sense of belonging, like to a family or a church 
[8, 9]. Support group participation in Zimbabwe also enabled individuals to speak openly 
with others in the same situation, facilitating an improved sense of self and greater 
acceptance of one’s HIV status [17]. Researchers likewise found improved peace of mind 
and diminished shame and stigma with support group participation in Tanzania [20]. 
Rwandan support group participants relayed feeling a sense of connectedness, becoming 
free of shame and having a sense of “rebirth” [18]. A study in Uganda also demonstrated the 
importance of connectedness and of belonging to a wider community of those living with 
HIV in facilitating treatment adherence [21].
Preserving Social Capital—A study in three resource-limited countries (Nigeria, 
Tanzania and Uganda) revealed that adherence and retention can ensue as a means of 
preserving social capital. That is, those living with HIV adhere to treatment to promote good 
will on the part of those they consider to be helpers (i.e., support group members, family 
members, and friends). This ensures that these helpers will be committed to assisting them 
in the future, when the need arises [4].
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Purpose of this Paper
The Mozambican MoH supported a multi-site level evaluation of the CASG program based 
on promising results in Tete Province. This paper describes the evaluation’s qualitative 
findings from the patient perspective on the role of social relationships, as facilitated through 
CASG, in improving treatment retention. As an increased number of Mozambican health 
facilities potentially implement CASG, these findings may be helpful in informing the 
facilities, staff members charged with directing CASG, and patient group leaders about what 
aspects of social relationships are important to foster within the groups. These findings may 
likewise serve to improve existing CASG programs within Mozambique by contributing to 
potential modifications to group facilitation and discussion. Lastly, the paper seeks to 
contribute to the qualitative body of literature emerging from resource-limited settings on 
how participating in support groups contributes to improved retention and adherence. The 
paper’s qualitative findings may thus be helpful to policymakers, health facility staff, and 
patients as they consider potential strategies to improve HIV treatment adherence and 
retention within their programs.
Methods
Qualitative Methods
We conducted focus groups to learn from patients about the CASG program’s perceived 
utility and their thoughts on if (and how) the program facilitated improved retention for 
themselves and others. We selected focus groups because they are appropriate for learning 
more about perceptions about programs and services, given they encourage the exploration 
and clarification of shared experiences. Focus groups can therefore contribute to an 
environment in which stories can be shared, and in which participants bound by common 
experience can expound upon the thoughts of others [22–25]. We therefore deemed focus 
groups to be the most appropriate method, as we aimed to gauge not only an individual 
patient’s own perceptions about the CASG program, but their reactions to what other 
patients thought as well. In addition, each CASG has a patient leader who serves as its 
facilitator and point of contact with the health facility. As CASG leaders routinely meet with 
one another at their health facilities, using a focus group methodology additionally enabled 
us to logistically tie into their existing meetings.
Site Selection
We conducted focus groups during November–December 2014 with CASG leaders at 10 
health facilities in Mozambique. We randomly selected the 10 sites from the 69 health 
facilities in Mozambique with existing CASG programs at the time of data collection. The 
sites were located in the provinces of Maputo City, Cabo Delgado, Maputo, Inhambane, 
Nampula, and Zambezia. For each site (n = 10), we conducted one focus group.
Participant Selection and Recruitment
We used key informant sampling to learn from highly knowledgeable patients (i.e., the 
CASG leaders) [24, 25]. We worked with health facility staff, who then approached their 
CASG leaders approximately 1 month in advance of the focus groups, describing the 
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purpose, the general topics for discussion, and that participation was voluntary. Those 
agreeing to participate received a reminder 1 week beforehand, followed by a SMS and 
phone call the day before the focus group. Focus groups comprised 6 to 10 CASG leaders 
per site, a number supported by the literature [22, 23].
Data Collection
Our data collection lead managed a team of nine individuals experienced in qualitative 
methods in piloting the semi-structured focus group instrument and collecting data at the 
sites. We designed the instrument to learn more from patient leaders about why they and 
others might join a CASG and any changes they observed in themselves or others as a result 
of participation. For all focus groups, one data collection team member served as the 
moderator, leading it in Portuguese, while another acted as note-taker and digital recorder. 
Not all focus group participants were fluent in Portuguese at four sites. A facility staff 
member joined these focus groups, translating questions from the moderator into the local 
language, and participants’ answers in the local language into Portuguese. Other focus group 
participants (fluent in both the local language and Portuguese) served as back translators, 
enhancing the reliability of the notes and digital recordings.
Data Management and Analysis
Members of the data collection team met daily to debrief, review notes for completeness, 
discuss common themes, and monitor for data saturation. They subsequently developed 
focus group transcripts in Portuguese from the digital recordings (adding annotations from 
their written notes), and uploaded them into QSR International’s NVivo version 10 for 
analytic purposes [26].
The data collection team then inductively drafted a codebook based on the transcripts. The 
co-authors reviewed the draft, provided feedback, and revised the codebook in collaboration 
with the data collection team. The codebook defined each code and coding guidelines, 
including example quotations. Two data collection team members then independently coded 
each of the 10 transcripts and used NVivo’s reliability tool to assess intra and inter-coder 
reliability [26]. Whenever two data collection team members found discordance, they 
discussed and resolved it in the presence of a third data collection team member who served 
as a moderator, ensuring 100% concurrence in the coding process. The data collection team 
additionally translated summaries of the coded information into English. The co-authors 
then synthesized the codes into themes, using the applied thematic analysis approach as a 
framework [27].
Results
Eighty-seven participants, 58 females (67%) and 29 males (33%), participated in the focus 
groups at the 10 health facilities. Most participants were 35 to 49 years old (64%), and had 
primary school education (70%). Some were living with a partner (41%).
Three major themes (and related sub-themes) emerged from the qualitative analysis 
concerning the means through which CASG participation can contribute to improved 
treatment adherence and retention: (1) time and financial benefits, (2) health educational 
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benefits, and (3) psychosocial benefits. Tables 1, 2 and 3 provide more information on these 
themes and sub-themes, accompanied by example quotations to assist in illuminating the 
findings.
Table 1 demonstrates the time and financial benefits that can accrue through CASG 
participation. It highlights the ways in which focus group participants reported that CASG 
saves them and other group members money, for example through decreased transportation 
costs and time away from work (with the potential for lost wages), given there is no longer a 
need to visit the health facility each month. Table 1 additionally highlights how CASG can 
result in time-savings for members by decreasing wait time at the health facility because of 
the priority status that members receive in line and/or because of CASG’s overall 
contribution to decreased patient volume. The table also depicts another financial benefit of 
CASG participation, access to mutual savings funds (or xitique, in Portuguese). Focus group 
participants described that money can be collectively pooled through CASGs to support 
members with their transportation costs when going to pick up medications, or aid those 
who might be ill or in general need of funds.
Table 2 depicts what we learned from focus group participants regarding the ability of 
CASG members to accrue health-educational benefits as a result of their CASG 
participation. This could take the form of knowledge sharing about the benefits of retention 
and adherence (including the importance of properly taking medications and receiving 
clinical follow-up) and the overall benefits of pursuing a healthy lifestyle.
Table 3 demonstrates the psycho-social benefits that can accrue through CASG participation. 
It highlights the ways in which focus group participants reported that being in CASG 
benefitted them psycho-socially, but also how it aided others, including members of their 
families and communities living with HIV. Focus group participants reported that CASG 
contributed to their greater acceptance of living with HIV and facilitated a sense of 
belonging within themselves. CASG members also reported psycho-socially aiding other 
group members by motivating them not to give up (i.e. in living with HIV), encouraging 
them to take their medications, visiting them when sick, and by providing food and other 
support. Focus group participants additionally shared how CASG enabled them to create a 
supportive extended family in which mutual understanding ensued because of their common 
HIV status, and in which certain cases could serve as a proxy for their own families. Some 
focus group participants also reported that their membership in CASG facilitated spiritual 
healing and/or spiritual connections.
Discussion
Time and Financial Benefits
We found from our focus group participants that CASG confers time and financial benefits 
to its members through: decreased transportation costs; decreased work absences, decreased 
patient volume and wait time at health facilities, and by facilitating access to mutual savings 
funds. Our findings corroborate findings from the CASG pilot on the time and cost savings 
that CASG participation can confer [8–10, 12]. Our findings additionally converge with 
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findings from the CASG pilot and a study in Zimbabwe on how support groups can facilitate 
access to mutual savings and financial assistance from other group members [17].
We found, as did a study in Rwanda [18], that support group participation could result in less 
time away from one’s workplace and source of income. Of note is that our study contributes 
to the qualitative literature in revealing that less time away from work could confer not only 
a financial benefit (i.e. less lost wages), but could also decrease concern about unintended 
disclosure, given that bosses and co-workers were reported to be less likely to wonder and 
inquire about an individual’s health (given fewer work absences). Future studies could 
benefit from exploring the potential of support group participation to decrease the fear of 
unintended disclosure and stigma, given improved health in general, and fewer absences 
from work in particular.
Health Educational Benefits
We learned from focus group participants that they accrued health-educational benefits from 
CASG participation in the form of knowledge sharing about the benefits of retention and 
adherence, the importance of properly taking medications and visiting the health facility, etc. 
Our study thus augments existing literature on how support group participation can facilitate 
information sharing about disease progression and the importance of daily drug intake [8–
10, 18], and the importance of attending clinical appointments [17].
We additionally found that CASG participation more generally encouraged a healthy 
lifestyle beyond just taking medication (e.g., using condoms and limiting the number of 
sexual partners, appropriate nutrition, and decreasing one’s smoking and alcohol 
consumption). While a study in South Africa found that the dynamics in a patient’s social 
environment could serve to encourage a healthy lifestyle and promote HIV treatment 
adherence [19], the ability of support groups in resource-constrained countries to more 
generally encourage a healthy lifestyle remains relatively unexplored in the literature. 
Additional studies to explore theoretical constructs pertaining to health promotion and 
behavior change such as socio-ecological theory [28, 29], could assist in illuminating the 
influences and dynamics through which individuals decide to pursue healthier behaviors, 
and what particular components of support group functioning are contributing factors.
Psycho‑social Benefits
Our focus group participants reported that being in CASG not only benefitted them directly, 
but also aided others, including members of their families and communities living with HIV. 
They shared that the opportunity to help others was an important benefit of their support 
group participation, potentially boosting their own psychosocial health. Such support of 
others could entail encouraging other group members to take their medication, visiting them 
while ill, or facilitating family and community members’ access to life-saving treatment by 
bringing them into a CASG. The “Helper” Therapy Principle initially postulated that the act 
of supporting others could potentially assist in healing the helper [30]. More study is needed 
of this particular dynamic and understanding of how individuals are motivated to potentially 
join and/or remain in a support group because of the ability to help others and what direct 
impact serving as a “helper” has on mental and physical health outcomes of interest.
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Our focus group participants also reported that CASG contributed to their greater acceptance 
of living with HIV and facilitated a sense of belonging. A salient point that additionally 
emerged was of CASG members motivating other group members not to give up (i.e. in 
living with HIV) by encouraging them to take their medications and by providing nutritious 
food and other support. Focus group participants also shared how CASG enabled them to 
create an extended family, a supportive one in which common understanding ensued because 
of their common HIV status. Like the CASG pilot in Tete and studies in Zimbabwe, 
Rwanda, Tanzania, and Uganda, we similarly found that participating in a support group 
could decrease feelings of isolation in living with HIV, enhance feelings of connectedness, 
improve peace of mind, and confer a sense of belonging, like to a family [8, 9, 17, 18, 20, 
21]. Of note is that the emergent body of qualitative literature in resource-constrained 
settings that demonstrates that support groups can have a beneficial impact upon retention 
and adherence all involve support groups comprising those living with HIV. This may be of 
interest to policy makers, clinicians, and communities considering how to structure social 
support to best boost retention and adherence, as it may be beneficial to thoroughly consider 
whether social support provided by non-HIV positive individuals (e.g., community workers, 
families or friends) would be equally as effective.
Of additional note is that a study conducted in Nigeria, Tanzania and Uganda revealed that 
adherence and retention can ensue as a means of preserving social capital (i.e., those living 
with HIV adhere to treatment to ensure that those they consider to be helpers such as support 
group members, family, and friends remain committed to assisting them in the future) [4]. 
This may suggest much more of a quid-pro-quo situation in which individuals living with 
HIV do what is expected or conform to normative behavior (i.e., adherence) to build up 
social capital to support themselves through future illnesses, financial difficulties, etc. This 
raises that the nature of relationships may be more symbiotic, rather than altruistic in nature. 
Such a notion of social relationships merits additional inquiry as well.
Lastly, some of our focus group participants shared that a benefit of CASG was spiritual 
healing and/or spiritual connections facilitated through group membership. These findings 
corroborate findings from the CASG pilot in Tete [8, 9], and we additionally illuminated that 
a CASG may get formed by those known to one another at church. The role of spirituality 
and of faith communities potentially serving as entities through which support group 
members can be recruited should not be underestimated as potentially important variables 
when considering support group composition, functioning and effectiveness.
Implications for the CASG Program in Mozambique and Emerging Models of HIV Care and 
Treatment
Our findings may be helpful in informing what elements of social relationships are critical to 
foster within CASGs as the Mozambican MoH further considers scaling up the program and 
other retention strategies. It is additionally important that the CASG program not only 
continues to foster these critical elements of social relationships, but is complemented with 
an enabling health system (e.g., shorter wait times for CASG members), to support 
continued programmatic effectiveness.
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This inquiry provides important information to the national HIV program in Mozambique on 
how CASG participants perceive the benefits of the program, and builds on existing 
evidence of CASG effectiveness in reducing attrition and lost to follow-up regardless of 
CD4 count [1, 31]. It demonstrates the importance of the social relationships among patients 
enrolled in CASG in helping members become and remain adherent. Documenting and 
learning from the patient perspective remains important in the era of test-and-start, and as 
some patients are moving to receiving 3-month prescriptions for ARVs under pilot programs 
in Mozambique.
While there is still much to learn about how social relationships affect adherence and 
retention in resource-constrained settings, we learned about the salient benefits that social 
relationships conferred through the CASG program in Mozambique. It is important to be 
cognizant of the types of financial, time, educational and psycho-social benefits that we 
found to be important in CASG, and to potentially consider if conferring similar benefits 
would be advantageous within other emerging models of social support for those living with 
HIV. Our findings further demonstrated that being part of and supported by a group of peers 
living with HIV was an important component of the CASG program. This may have 
implications for models where social support is provided through non-peer groups (e.g., 
families, community-based NGOs, and/or health care providers).
Limitations
We employed a key informant sampling strategy, enabling patients with the richest and most 
information about the CASG program (i.e. CASG leaders) to participate. Our focus group 
participants may therefore have been more inclined to emphasize program benefits and 
underestimate shortcomings, given their leadership roles. The generalizability of our 
findings to represent the perceptions of all CASG participants, may therefore be limited, and 
our use of purposive sampling (i.e. a non-random approach) may limit the generalizability of 
our findings overall. A majority of our focus group participants were 35–49 years old. There 
is a possibility that younger or older patients may have had different perspectives on the 
CASG program than those in this age range. CASGs also vary in their composition. 
Although we did not attempt to understand how group composition impacts adherence and 
retention, this is an important question for future inquiries. In addition, while our focus 
group participants reported improved adherence, we did not directly link their self-reports 
with viral load testing results as a quantifiable measure of adherence. We also did not 
explore why CASG members are more likely to be women, and why some patients elect not 
to join a group. These are important issues to elucidate in the future to potentially address 
the low uptake of CASG amongst men [1]. Health facilities with CASGs also vary in their 
levels of support for the program, which may influence the extent to which their CASGs 
facilitate adherence and retention. Access to HIV treatment services also geographically 
varies across Mozambique. Patients may therefore be more inclined to join and benefit from 
a CASG where there are shortages of health facilities, and/or where transportation costs 
would be higher, and time spent away from home (and/or work) longer. Future inquiries 
would benefit from considering such geographic variability in CASG and the benefits it 
confers to patients. We also conducted the focus groups in 2014. Although there is no 
evidence from this analysis or prior publications of patient perspectives on CASG 
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participation changing over time, a follow-up study could be helpful in confirming. Lastly, 
this paper does not explore how the CASG program could be improved nor the program’s 
impact on health systems. This area of inquiry could also benefit from additional 
consideration.
Conclusions
This paper describes findings from a multi-site evaluation of the CASG program in 
Mozambique, specifically in exploring the role of social relationships in improving patient 
adherence and retention. These findings may be helpful in informing what elements of social 
relationships are critical to foster within CASGs as the Mozambican MoH expands the 
program nationally.
This paper additionally contributes to the emerging qualitative literature on how support 
group participation contributes to improved HIV treatment outcomes in resource-limited 
settings, and to more generally inform others in such settings about salient aspects of social 
relationships to potentially consider within emerging models of social support for those 
living with HIV.
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Table 2
Theme—health educational benefits accruing from CASG participation
Sub-themes Example quotations
Treatment 
adherence
One focus group participant offered:
“It helped me … in moving forward … in managing my health. You’re doing a lot of things by the fact you’re managing 
yourself. The biggest thing is taking the medication that the doctors give you. ….not taking the medication is what 
makes your days short ……”
Another focus group participant highlighted changes in a group member:
“Before he entered CASG, he wasn’t adherent. He didn’t want to always take his medication, so there were always 
illnesses. To cut his grass, he was left really weak. But now when he entered the group … he is taking his medication 
…..And just like that, he’s there cutting his grass and does everything.”
A healthy lifestyle One focus group participant explained that
being healthy goes beyond taking medication:
“In my group, they teach us to take the medication on time … and that even if she [a group member] has a boyfriend, 
she has to always use the condom … she has to know how to reduce the number of these boyfriends ….. the medicine 
can’t make any effect if she takes it, and then does nothing [about risky behaviors].”
Another described how the CASG tried to counsel one of its group members about the negative impact of her smoking 
and alcohol consumption before she died:
“She was drinking a lot and smoking cigarettes. My group …. we tried to advise her … we talked with her at least three 
times, of wanting to put her in line, but we lost her, she’s just not with us.”
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